methylene blue has been researched along with Hepatic Encephalopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, JL; Arias, N; Fidalgo, C; Méndez, M | 1 |
| Antonini, E; Capocaccia, L; Carlone, S; Farber, MO; Manfredi, F; Rossi-Fanelli, F; Serra, P | 1 |
| Aeschlimann, C; Cerny, T; Küpfer, A | 1 |
3 other study(ies) available for methylene blue and Hepatic Encephalopathy
| Article | Year |
|---|---|
Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Electron Transport Complex IV; Enzyme Inhibitors; Hepatic Encephalopathy; Hippocampus; Low-Level Light Therapy; Male; Methylene Blue; Neostriatum; Prefrontal Cortex; Rats, Wistar | 2021 |
The oxygen affinity of hemoglobin in hepatic encephalopathy.
Topics: Female; Hemoglobins; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Methylene Blue; Middle Aged; Oxygen; Oxyhemoglobins | 1981 |
Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Topics: Administration, Oral; Animals; Antidotes; Antineoplastic Agents, Alkylating; Brain Diseases; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Ifosfamide; Methylene Blue; Oxidation-Reduction; Rats | 1996 |